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Objective: 
The aim of this study was to 
determine the in vitro activity 
of different phenolic 
compounds against H. pylori 
clinical isolates by a disc 
diffusion method.
Methods: 
• 28 H. pylori clinical isolates were obtained from 
gastric biopsies from patients suffering of gastric 
symptomatology. 
• Biopsies were processed following standard 
methodology for these bacteria.
• The in vitro activity of different phenolic 
compounds was studied by a disc diffusion 
method: Epicatechin, gallic acid, resveratrol, 
coumaric acid, ferulic acid, methyl gallate, 
catechin, quercetin, vanillic acid and kaempferol. 
• Compounds were diluted in ethanol:water 
(10:90 v/v) at 25mM concentration. Ethanol was 
used in the same conditions than phenolic 
compounds to rule out its activity.
• Blank disc were impregnated with 10mcl of each 
compound and were put in agar Columbia plus 
7% sheep blood inoculated with a suspension of 
a 2 McFarland H. pylori. 
• Plates were incubated for 3 to 5 days at 37ºC in 
a 10% CO2 atmosphere. Inhibition zone around 
disc were measured.
Results: 
-The number of strains inhibited for the 
different compounds tested are shown in the 
table. 
- Figure 1 showed the inhibition zone 
detected with compounds. 
- Gallic acid, coumaric acid and furelic acid 
did not inhibit the strains tested. Ethanol 
produced not inhibition in the strains tested.
Conclusions: 
Two of the phenolic 
compounds tested in this 
study (Resveratrol and 
methyl gallate) showed in 
vitro activity against all 
Helicobacter pylori clinical 
isolates tested by a disc 
diffusion method.
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